Kirenol alleviates diabetic nephropathy via regulating TGF-β/Smads and the NF-κB signal pathway-Reference-Cited by-同舟云学术

Kirenol alleviates diabetic nephropathy via regulating TGF-β/Smads and the NF-κB signal pathway

Published:2022-09-08 Issue:1 Volume:60 Page:1690-1700
ISSN:1388-0209
Container-title:Pharmaceutical Biology
language:en
Short-container-title:Pharmaceutical Biology

Author:

Li Jialin¹²,Zhang Jiawen³,Yang Meng³,Huang Xiaocui³,Zhang Meng³,Fang Xiansong⁴,Wu Suzhen¹³^ORCID

Affiliation:

1. Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education, Gannan Medical University, Ganzhou, China

2. School of Pharmacy, Gannan Medical University, Ganzhou, China

3. School of Basic Medicine, Gannan Medical University, Ganzhou, China

4. First Affiliated Hospital, Gannan Medical University, Ganzhou, China

Funder

the Open Project of Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, Ministry of Education

Science and Technology Innovation Team Project of Gannan Medical University

Fund of Gannan Medical University

Natural Science Foundation of Jiangxi Province

National Natural Science Foundation of China

Talents’ Start-up Fund of Gannan Medical University

Publisher

Informa UK Limited

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13880209.2022.2112239

Reference45 articles.

1. Ginsenoside Rg1 and the control of inflammation implications for the therapy of type 2 diabetes: A review of scientific findings and call for further research

2. Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition

3. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose

4. Shenqiwan Ameliorates Renal Fibrosis in Rats by Inhibiting TGF-β1/Smads Signaling Pathway

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barleriside A, an aryl hydrocarbon receptor antagonist, ameliorates podocyte injury through inhibiting oxidative stress and inflammation;Frontiers in Pharmacology;2024-08-22

2. NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies;Heliyon;2024-05

3. Research progress in arthritis treatment with the active components of Herba siegesbeckiae;Biomedicine & Pharmacotherapy;2023-12

4. Lupenone improves type 2 diabetic nephropathy by regulating NF-κB pathway-mediated inflammation and TGF-β1/Smad/CTGF-associated fibrosis;Phytomedicine;2023-09

5. Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway;Drug Design, Development and Therapy;2023-07